| 1 | SELLAS Life Sciences Group, Inc.SLS | 61.4% | 17.95USD-6.27% |
| 2 | Capricor Therapeutics, Inc.CAPR | 63.3% | 8.03USD-4.52% |
| 3 | Akanda Corp.AKAN | 74.7% | 4.03USD+96.6% |
| 4 | UnitedHealth Group Inc.UNH | 45.7% | 349.91USD-10.2% |
| 5 | Altimmune, Inc.ALT | 42.6% | 1.39USD-9.15% |
| 6 | ImmunityBio Inc.IBRX | 85.3% | 6.70USD+7.03% |
| 7 | Clover Health Investments, Corp. Class A Common StockCLOV | 33% | 4.17USD-11.8% |
| 8 | Candel Therapeutics, Inc.CADL | 84.8% | 5.32USD-1.48% |
| 9 | Iovance Biotherapeutics, Inc.IOVA | 59.5% | 7.48USD-0.66% |
| 10 | Tilray Brands Inc.TLRY | 34.9% | 2.25USD-4.26% |
| 11 | Aurora Cannabis Inc.ACB | 33.3%from 2 mentions | 4.40USD-2.65% |
| 12 | Viking Therapeutics IncVKTX | 62.4% | 26.17USD-2.64% |
| 13 | Quest Diagnostics IncorporatedDGX | 44.9% | 259.69USD+1.3% |
| 14 | Inovio Pharmaceuticals Inc.INO | 93% | 1.69USD+3.68% |
| 15 | Novo Nordisk A/S Sponsored ADRNVO | 33% | 39.43USD-3.12% |
| 16 | Compass Pathways plc - ADRCMPS | 95.9% | 8.12USD+1.75% |
| 17 | Cue Biopharma, Inc.CUE | 76.1% | 4.76USD+68.2% |
| 18 | Moderna Inc.MRNA | 46.2% | 196.79USD-4.84% |
| 19 | Gain Therapeutics, Inc.GANX | 79.5% | 1.11USD-5.93% |
| 20 | Novavax Inc.NVAX | 73.2% | 7.96USD0% |
| 21 | Akebia Therapeutics Inc.AKBA | 55.1% | 0.41USD+2.23% |
| 22 | Outlook Therapeutics, Inc.OTLK | 80.8% | 0.41USD+13% |
| 23 | SeaStar Medical Holding CorporationICU | 60% | 1.04USD+33.2% |
| 24 | MannKind CorporationMNKD | 85.5% | 4.07USD0% |
| 25 | Incannex Healthcare Inc.IXHL | 29.9% | 1.75USD+0.57% |
| 26 | Merck & Co., Inc.MRK | 97.1% | 137.78USD-3.9% |
| 27 | Ocugen, Inc.OCGN | 60.9% | 0.74USD-2.35% |
| 28 | Hims & Hers Health, Inc.HIMS | 55.4% | 17.05USD-2.85% |
| 29 | CorMedix Inc.CRMD | 45.8% | 4.50USD-3.64% |
| 30 | NRx Pharmaceuticals, Inc.NRXP | 78.9% | 2.80USD+14.3% |
| 31 | Tonix Pharmaceuticals Holding Corp.TNXP | 44.9% | 2.82USD-4.08% |
| 32 | TG Therapeutics Inc.TGTX | 95.2% | 66.12USD+5.44% |
| 33 | BioCryst Pharmaceuticals, Inc.BCRX | 55.6% | 7.30USD-2.67% |
| 34 | Omeros Corp.OMER | 81.6% | 14.55USD+4.53% |
| 35 | Eli Lilly and CompanyLLY | 60.4% | 1,382.75USD-2.32% |
| 36 | Quantum-Si Incorporated Class A Common StockQSI | 84.5% | 1.07USD+5.94% |
| 37 | Greenwich LifeSciences, Inc.GLSI | 97.8% | 20.58USD+10.1% |
| 38 | MoonLake Immunotherapeutics Class A Ordinary SharesMLTX | 51.4% | 10.79USD-4.09% |
| 39 | Cardiff Oncology Inc.CRDF | 52.4% | 0.84USD-1.29% |
| 40 | Autolus Therapeutics plc ADRAUTL | 73.5% | 1.06USD-2.75% |
| 41 | Coherus Oncology, Inc.CHRS | 14.3% | 0.41USD-14.4% |
| 42 | Conduit Pharmaceuticals IncCDT | 83.3% | 0.34USD-4.72% |
| 43 | Ardelyx Inc.ARDX | 88.6% | 3.12USD-1.89% |
| 44 | PDS Biotechnology CorporationPDSB | 64.4% | 0.78USD-12.3% |
| 45 | Actinium Pharmaceuticals, Inc.ATNM | 58.3% | 1.08USD-20% |
| 46 | Anavex Life Sciences Corp.AVXL | 63.2% | 0.72USD-2.78% |
| 47 | Sarepta Therapeutics, Inc.SRPT | 74.2% | 14.53USD-1.62% |
| 48 | Invivyd, Inc. Common StockIVVD | 37.1% | 0.47USD-8.28% |
| 49 | PolyPid Ltd.PYPD | 96.2% | 6.56USD+0.31% |
| 50 | Annovis Bio, Inc.ANVS | 64.9% | 0.84USD+13.6% |
| 51 | Galectin Therapeutics Inc.GALT | 76.9% | 2.98USD+2.41% |
| 52 | Summit Therapeutics Inc.SMMT | 59.1% | 10.50USD-1.59% |
| 53 | Milestone Pharmaceuticals Inc.MIST | 75.9% | 0.46USD+11.5% |
| 54 | Cingulate Inc.CING | 70% | 5.11USD+8.26% |
| 55 | Oncolytics Biotech Inc.ONCY | 94.1% | 0.44USD+15.9% |
| 56 | Recursion Pharmaceuticals, Inc. Class A Common StockRXRX | 78.1% | 2.83USD+3.86% |
| 57 | Savara Inc.SVRA | 84% | 4.72USD+5.36% |
| 58 | Precigen Inc.PGEN | 100% | 4.27USD-0.47% |
| 59 | Axsome Therapeutics Inc.AXSM | 68.4% | 134.00USD-1.43% |
| 60 | Scilex Holding Co.SCLX | 63.2% | 0.63USD-2.29% |
| 61 | InflaRx N.V.IFRX | 57.6% | 1.11USD-3.48% |
| 62 | Senseonics Holdings, Inc.SENS | 15.6% | 9.74USD-4.13% |
| 63 | Molina Healthcare Inc.MOH | 13.5% | 206.56USD-6.62% |
| 64 | Cabaletta Bio Inc.CABA | 43.5% | 1.06USD+3.43% |
| 65 | Vanda Pharmaceuticals Inc.VNDA | 60% | 3.75USD-1.57% |
| 66 | Xeris Biopharma Holdings, Inc.XERS | 76.6% | 16.99USD+1.13% |
| 67 | Aurinia Pharmaceuticals IncAUPH | 38.5% | 15.13USD-1.75% |
| 68 | Johnson & JohnsonJNJ | 76.9% | 272.70USD-2.15% |
| 69 | Humana Inc.HUM | 37.9% | 385.78USD-13% |
| 70 | Biomea Fusion Inc.BMEA | 71.4% | 0.53USD+8.61% |
| 71 | Verastem Inc.VSTM | 31.8% | 6.87USD-7.29% |
| 72 | AbCellera Biologics Inc.ABCL | 94.7% | 11.02USD-0.09% |
| 73 | Abivax SA Sponsored ADRABVX | 81.4%from 6 mentions | 83.83USD+2.11% |
| 74 | Maia Biotechnology Inc.MAIA | 71.9% | 1.30USD+4% |
| 75 | CVS Health Corporation Common StockCVS | 30.8% | 81.35USD-5.2% |
| 76 | Takeda Pharmaceutical Co Ltd ADRTAK | 100%from 1 mention | 21.27USD-1.71% |
| 77 | Align Technology Inc.ALGN | 0%from 0 mentions | 163.96USD+0.31% |
| 78 | IDEAYA Biosciences Inc.IDYA | 66.7% | 26.49USD-3.32% |
| 79 | Scinai Immunotherapeutics Ltd. American Depositary SharesSCNI | 59.4% | 0.37USD-1.4% |
| 80 | Lexicon Pharmaceuticals, Inc.LXRX | 87.5%from 8 mentions | 1.72USD-3.37% |
| 81 | GSK plc ADRGSK | 100%from 2 mentions | 48.58USD-1.34% |
| 82 | Co-Diagnostics Inc.CODX | 30% | 0.20USD+0.87% |
| 83 | Ocular Therapeutix, Inc.OCUL | 83.9% | 5.94USD-1.33% |
| 84 | Kura Oncology, Inc.KURA | 73.9% | 7.34USD-2% |
| 85 | Aquestive Therapeutics Inc.AQST | 82.6% | 3.78USD+2.16% |
| 86 | Lineage Cell Therapeutics, Inc.LCTX | 61.5% | 0.84USD+2.26% |
| 87 | Canopy Growth CorporationCGC | 46.4% | 0.50USD-5.56% |
| 88 | Aptevo Therapeutics Inc.APVO | 69.2% | 0.45USD-3.25% |
| 89 | Agenus Inc.AGEN | 87.5% | 6.40USD+3.06% |
| 90 | AtaiBeckley Inc.ATAI | 0%from 0 mentions | 0.71USD-5.04% |
| 91 | Perspective Therapeutics Inc.CATX | 57.9% | 0.78USD-9.29% |
| 92 | Lantern Pharma Inc.LTRN | 56.3% | 0.33USD-9.78% |
| 93 | Kyverna Therapeutics, Inc.KYTX | 38.5% | 4.48USD-4.68% |
| 94 | Pfizer Inc.PFE | 69.2% | 28.06USD-1.44% |
| 95 | Mineralys Therapeutics, Inc.MLYS | 47.1% | 13.78USD-4.83% |
| 96 | Natera, Inc.NTRA | 71.4%from 5 mentions | 289.50USD+0.71% |
| 97 | EyePoint, Inc. Common StockEYPT | 70% | 0.27USD-9.33% |
| 98 | Black Diamond Therapeutics, Inc.BDTX | 100% | 1.43USD-0.69% |
| 99 | Oscar Health, Inc. Class A Common StockOSCR | 40% | 27.57USD-7.61% |
| 100 | DataMeds AI Inc.MEDS | 60% | 0.74USD+15.5% |